| Texto completo | |
| Autor(es): |
Kirkman, Tim
;
Sketcher, Alice
;
Barroso, Vinicius de Morais
;
Ishida, Kelly
;
Tosin, Manuela
;
Bertacine Dias, Marcio Vinicius
Número total de Autores: 6
|
| Tipo de documento: | Artigo Científico |
| Fonte: | ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY; v. 79, p. 11-pg., 2023-08-01. |
| Resumo | |
Candida auris has emerged as a global health problem with a dramatic spread by nosocomial transmission and a high mortality rate. Antifungal therapy for C. auris infections is currently limited due to widespread resistance to fluconazole and amphotericin B and increasing resistance to the front-line drug echinocandin. Therefore, new treatments are urgently required to combat this pathogen. Dihydrofolate reductase (DHFR) has been validated as a potential drug target for Candida species, although no structure of the C. auris enzyme (CauDHFR) has been reported. Here, crystal structures of CauDHFR are reported as an apoenzyme, as a holoenzyme and in two ternary complexes with pyrimethamine and cycloguanil, which are common antifolates, at near-atomic resolution. Preliminary biochemical and biophysical assays and antifungal susceptibility testing with a variety of classical antifolates were also performed, highlighting the enzyme-inhibition rates and the inhibition of yeast growth. These structural and functional data might provide the basis for a novel drug-discovery campaign against this global threat. (AU) | |
| Processo FAPESP: | 21/01279-5 - Investigação de novos alvos e moléculas antifúngicas sobre Candida spp. e Cryptococcus spp. |
| Beneficiário: | Kelly Ishida |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |
| Processo FAPESP: | 20/03850-9 - Parede celular micobacteriana: estudo estrutural e estratégias de inibição de enzimas relacionadas com sua biossíntese e regulação |
| Beneficiário: | Marcio Vinicius Bertacine Dias |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |
| Processo FAPESP: | 18/11612-0 - Investigação da atividade antifúngica e do mecanismo de ação de derivados 2-ariloxazolinas sobre Candida albicans |
| Beneficiário: | Vinicius de Morais Barroso |
| Modalidade de apoio: | Bolsas no Brasil - Doutorado |